The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning to people using the sleep disorder drug modafinil while pregnant, due to an association with increased risk of birth defects.
The post Sleep disorder drug modafinil linked to increased risk of birth defects appeared first on Health Europa.
Saturday 16 January 2021
healtheuropa - 2 month ago
Sleep disorder drug modafinil linked to increased risk of birth defects
Latest News
